Ayurcann Holdings Corp. (
CSE:
AYUR,
OTCQB: CDCLF,
FSE:
3ZQ0) (“
Ayurcann” or the
“
Corporation”), a leading Canadian cannabis
extraction company specializing in the processing and
co-manufacturing of pharma-grade cannabis and hemp to produce
various Cannabis 2.0 products in the medical and recreational
cannabis markets, is pleased to announce the approval of 15
additional product listings in the Vape, Concentrates and Flower
categories in the Provinces of Ontario, Alberta, Saskatchewan and
Manitoba.
Ayurcann will launch additional lines of
products under its house brands ‘Fuego’, ‘H&S’, ‘XPLOR’,
‘JOINTS’ and ‘BRAVO6’. New products include various innovations in
Distillate Vapes, Resin Vapes and Multi-Cannabinoid Vapes,
including CBN, high potency CBD oils and high potency Dablicators.
With cannabis flower sales growing across the Canadian recreational
market Ayurcann is pleased with the acceptance of 8 new product
stock keeping units (“SKUs”) and will be offering
high potency milled, pre-rolled and value flower. All products will
be made available through adult-use stores, including authorized
retailers across Canada.
Ayurcann will be launching the products
across Canada, which will allow for greater market penetration,
including faster and more scaled distribution. Ayurcann has been
executing its strategy to expand its market share in extract and
extract derivatives, while providing exceptional products and value
to consumers.
“We are thrilled with the growth of Ayurcann and
its products within the Canadian marketplace. With the ability to
produce products that are embraced by cannabis consumers, offering
value and innovation, we are optimistic about our future growth,
and the potential of becoming an industry leader. We have been
successfully selling throughout various Provinces within Canada,
including Ontario, British Columbia, Alberta, New Brunswick,
Manitoba, and Saskatchewan, and believe that the continued interest
from consumers and retailers will help elevate Ayurcann as a leader
in the industry”, said Igal Sudman, Chief Executive Officer of
Ayurcann.
About Ayurcann Holdings
Corp.
Ayurcann is a leading post-harvest solution
provider focusing on providing and creating custom processes and
pharma-grade products for the adult use and medical cannabis
industry in Canada. Ayurcann is striving to become a partner of
choice for leading Canadian and international cannabis brands by
providing best-in-class, proprietary services, including
extraction, formulation, product development and custom
manufacturing.
For additional information, please
contact:
Ayurcann Holdings Corp.Igal Sudman, Chief Executive
Officer905-492-3322info@ayurcann.com
Investor Relations:
Email: ir@ayurcann.com
Neither the Canadian Securities Exchange nor its
Regulation Services Provider have reviewed or accept responsibility
for the adequacy or accuracy of this news release.
This news release contains “forward-looking
statements” within the meaning of applicable securities laws. All
statements contained herein that are not clearly historical in
nature may constitute forward-looking statements. Generally, such
forward-looking information or forward-looking statements can be
identified by the use of forward-looking terminology such as
“plans”, “strategy”, “expects” or “does not expect”, “intends”,
“continues”, “anticipates” or “does not anticipate”, or “believes”,
or variations of such words and phrases or may contain statements
that certain actions, events or results “will be taken”, “will
launch” or “will be launching”, “will include”, “will allow”, “will
be made” “will continue”, “will occur” or “will be achieved”. The
forward-looking information and forward-looking statements
contained herein include, but are not limited to, statements
regarding: the Corporation selling cannabis flower products
pursuant to its licenses and in compliance with applicable laws;
the Corporation offering an expanded portfolio of products under
its existing brands; the Corporation continuing to develop its
products, including Distillate Vapes, Resin Vapes and
Multi-Cannabinoid Vapes; the Corporation offering new SKUs of
milled, pre-rolled and value flowers, and selling these products in
adult-use stores throughout the country; the Corporation leveraging
its current relationships for greater market penetration, including
faster and more scaled distribution of its new and existing
products; the Corporation expanding its market share in extract and
extract derivatives; the Corporation providing exceptional products
and value to consumers; the Corporation growing and becoming an
industry leader; the Corporation retaining and expanding its
consumer base to elevate as a leader in the industry; and the
ability of the Corporation to become the partner of choice for
leading Canadian and international cannabis brands
Forward-looking information in this news release
are based on certain assumptions and expected future events,
namely: the Corporation will expand and be able to maintain
production capacity; continued approval of the Corporation’s
activities by the relevant governmental and/or regulatory
authorities; the Corporation’s ability to continue as a going
concern; the continued growth of the Corporation; the Corporation’s
successful implementation of its strategy to expand market share in
extract and extract derivatives while providing exceptional
products to consumers; the Corporation’s continuing ability to meet
the requirements necessary to remain listed on the Canadian
Securities Exchange and alternative exchanges; the Corporation
selling its products, including dried cannabis flower, pursuant to
applicable laws and regulations; the Corporation leveraging its
current relationships to scale the distribution of its products and
offer an expanded portfolio of products, including pre-rolls,
milled and dried flower; the Corporation successfully distributing
new SKUs and increasing sales; the Corporation growing its
exposure, consumer and retail partnerships and market share
throughout the country; the Corporation maintaining a continuous
path of growth, and becoming an industry leader; the Corporation
maintaining and forging relationships with retail distributors and
becoming the partner of choice for leading Canadian and
international cannabis brands; the Corporation launching,
developing and distributing additional lines of products, including
extract and extract derivative products; the Corporation
distributing its products through adult-use stores; and the
Corporation acquiring and maintaining sufficient funds for
developing its products and improving the distribution process.
These statements involve known and unknown
risks, uncertainties and other factors, which may cause actual
results, performance or achievements to differ materially from
those expressed or implied by such statements, including but not
limited to: the Corporation’s inability to expand and/or maintain
production capacity; the potential inability of the Corporation to
continue as a going concern; the risks associated with the cannabis
industry in general; increased competition in the cannabis
extraction market; the potential future unviability of the cannabis
market; risks associated with potential governmental and/or
regulatory action with respect to the cannabis industry; the
Corporation’s inability to obtain continued regulatory approvals;
the Corporation’s inability to successfully implement its strategy
to expand market share in extract and extract derivatives and
provide exceptional products to consumers; the Corporation’s
inability to meet the requirements necessary to remain listed on
the Canadian Securities Exchange and alternative exchanges; the
Corporation’s inability to sell pre-rolls, milled and dried
cannabis flower products pursuant to applicable laws and
regulations; the Corporation’s inability to leverage its current
relationships in scaling the distribution of its products and/or
offer an expanded portfolio of products, including pre-rolls,
milled and dried cannabis flower; the Corporation’s inability to
grow and increase sales; the Corporation’s inability to grow its
exposure and/or market share; the Corporation’s inability to
maintain a continuous path of growth; the Corporation’s inability
to launch additional products under its house brands; the
Corporation’s inability to secure funds for the integration,
development and distribution of its new and existing products; the
Corporation’s inability to enter into new partnership and/or
distribute its new products through existing partnerships with
retail distributors across the country; the Corporation’s inability
to attract interest to its products from existing and potential
retail distributors; the Corporation’s inability to enter new
markets, secure additional partnerships and become the partner of
choice for leading Canadian and international cannabis brands; the
Corporation’s inability to become a leader in the cannabis
industry; and the Corporation’s inability to distribute its
products through adult-use stores.
Readers are cautioned that the foregoing list is
not exhaustive. Readers are further cautioned not to place undue
reliance on forward-looking statements, as there can be no
assurance that the plans, intentions, or expectations upon which
they are placed will occur. Such information, although considered
reasonable by management at the time of preparation, may prove to
be incorrect and actual results may differ materially from those
anticipated.
Forward-looking statements contained in this
news release are expressly qualified by this cautionary statement
and reflect the Corporation’s expectations as of the date hereof
and are subject to change thereafter. The Corporation undertakes no
obligation to update or revise any forward-looking statements,
whether as a result of new information, estimates or opinions,
future events, or results or otherwise or to explain any material
difference between subsequent actual events and such
forward-looking information, except as required by applicable
law.
Caisse des Dpts et Consi... (EU:CDCLF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Caisse des Dpts et Consi... (EU:CDCLF)
Historical Stock Chart
From Sep 2023 to Sep 2024